Nirman Bio Pharma Private Limited

Manufactures and trades pharmaceuticals, antibiotics, medicines, vaccines, and allied products.

2021 | Delhi (India) | Active
Last Updated: December 19, 2024

Nirman Bio Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year,
  • Last Filing with ROC 31 Mar 2024

About Nirman Bio Pharma

Nirman Bio Pharma Private Limited (NBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 February 2021 (Four years 0 days old ). Its registered office is in Delhi, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Sunil Kumar and Anuradha Kumari serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24299DL2021PTC376745

  • Company No.

    376745

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    09 Feb 2021

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Pharma

Who are the key members and board of directors at Nirman Bio Pharma?

Board Members (2)

Name Designation Appointment Date Status
Sunil Kumar Country flag representing In Director 09-Feb-2021 Current
Anuradha Kumari Country flag representing In Director 09-Feb-2021 Current

Financial Performance of Nirman Bio Pharma.

Nirman Bio Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Nirman Bio Pharma?

In 2023, Nirman Bio Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Nirman Bio Pharma?

Nirman Bio Pharma has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nirman Bio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nirman Bio Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Nirman Bio Pharma

Recent activity within the organization

  • Annual General Meeting

    Nirman Bio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Nirman Bio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

    31 Mar 2024

  • Director Appointment

    Sunil Kumar was appointed as a Director was appointed as a Director on 09 Feb 2021 & has been associated with this company since 4 years .

    09 Feb 2021

  • Director Appointment

    Anuradha Kumari was appointed as a Director was appointed as a Director on 09 Feb 2021 & has been associated with this company since 4 years .

    09 Feb 2021

  • Company Incorporation

    Nirman Bio Pharma Private Limited was registered on 09 Feb 2021 with Roc Delhi & aged 4 years as per MCA records.

    09 Feb 2021

Frequently asked questions

  • Nirman Bio Pharma Private Limited was incorporated on 09 Feb 2021.

  • The authorized share capital of Nirman Bio Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 2 directors are associated with Nirman Bio Pharma Private Limited.

    • Sunil Kumar
    • Anuradha Kumari
  • As per Ministry of Corporate Affairs (Mca), the registered address of Nirman Bio Pharma Private Limited is Shop No G-18 Plot 5 Ground Floor Cs/Ocf Rk Plaza Sec 21 Rohini Ph 3 India, Delhi, 110086.

  • The corporate identification number (CIN) of Nirman Bio Pharma Private Limited is U24299DL2021PTC376745 and the company number is 376745 as per Ministry of Corporate Affairs (MCA).

  • The most recent Balance Sheet for Nirman Bio Pharma Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development